Completed
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia
NCT01556763
- Conditions
- Central Nervous System Diseases, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Clinical Research Institute Wichita, Kansas, United States